Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells

F. Vignon, Marc E Lippman, H. Nawata, D. Derocq, H. Rochefort

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In an attempt to approach the mechanism by which estrogen and antiestrogen regulate the growth of estrogen receptor-positive breast cancer, we have studied the effects of the antiestrogens tamoxifen (TAM) and 4-hydroxytamoxifen (OH-TAM) on the induction of two estrogen-specific proteins in a variant of MCF7 cells termed R27, cloned for its ability to grow in the presence of TAM. We found that, in the R27 variant, antiestrogens as well as estradiol were able to increase specifically the production of a M(r) 52,000 protein which was released into the culture medium. This protein was shown to be identical to the M(r) 52,000 glycoprotein induced by estrogen and released by MCF7 cells on the basis of its specific inducibility by physiological concentrations of 17β-estradiol and of its resolution in two-dimensional gel analysis. Dose-response analysis showed that, in the R27 variant, TAM and OH-TAM acquired the ability to induce the M(r) 52,000 protein at concentrations compatible with their relative affinities for the estrogen receptor, while these antiestrogens were inefficient in the wild MCF7 cells. Whereas the relative increase of the M(r) 52,000 protein was similar with TAM, OH-TAM, and 17β-estradiol, the general production of M(r) 52,000 and of total labelled proteins was less with the antiestrogens than with 17β-estradiol. Moreover, OH-TAM displayed a biphasic dose-response curve with inhibitory effects at concentrations above 10 nM, suggesting an additional mechanism. Neither TAM nor OH-TAM had any antiestrogenic effect when added in the presence of 17β-estradiol. In the R27 variant, both estradiol and antiestrogens induced the progesterone receptor sites; however, the extent of the stimulation was lower with antiestrogens than with estradiol. This study shows that, in addition to the classical antiestrogen-resistant breast cancer cells, in which the estrogen receptor is absent or inactive, there is another class of antiestrogen-resistant cells in which the drug becomes a full estrogen agonist as evidenced by the induction of the M(r) 52,000 estrogen-specific protein, which is not induced in the wild-type cells.

Original languageEnglish
Pages (from-to)2084-2088
Number of pages5
JournalCancer Research
Volume44
Issue number5
StatePublished - Jul 5 1984
Externally publishedYes

Fingerprint

Estrogen Receptor Modulators
MCF-7 Cells
Tamoxifen
Estrogens
Clone Cells
Estradiol
Proteins
Estrogen Receptors
Breast Neoplasms
Progesterone Receptors
Culture Media
Glycoproteins
Gels
hydroxide ion

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vignon, F., Lippman, M. E., Nawata, H., Derocq, D., & Rochefort, H. (1984). Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. Cancer Research, 44(5), 2084-2088.

Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. / Vignon, F.; Lippman, Marc E; Nawata, H.; Derocq, D.; Rochefort, H.

In: Cancer Research, Vol. 44, No. 5, 05.07.1984, p. 2084-2088.

Research output: Contribution to journalArticle

Vignon, F, Lippman, ME, Nawata, H, Derocq, D & Rochefort, H 1984, 'Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells', Cancer Research, vol. 44, no. 5, pp. 2084-2088.
Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. Cancer Research. 1984 Jul 5;44(5):2084-2088.
Vignon, F. ; Lippman, Marc E ; Nawata, H. ; Derocq, D. ; Rochefort, H. / Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. In: Cancer Research. 1984 ; Vol. 44, No. 5. pp. 2084-2088.
@article{4988d11d0d694883b9af1fbaad605acf,
title = "Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells",
abstract = "In an attempt to approach the mechanism by which estrogen and antiestrogen regulate the growth of estrogen receptor-positive breast cancer, we have studied the effects of the antiestrogens tamoxifen (TAM) and 4-hydroxytamoxifen (OH-TAM) on the induction of two estrogen-specific proteins in a variant of MCF7 cells termed R27, cloned for its ability to grow in the presence of TAM. We found that, in the R27 variant, antiestrogens as well as estradiol were able to increase specifically the production of a M(r) 52,000 protein which was released into the culture medium. This protein was shown to be identical to the M(r) 52,000 glycoprotein induced by estrogen and released by MCF7 cells on the basis of its specific inducibility by physiological concentrations of 17β-estradiol and of its resolution in two-dimensional gel analysis. Dose-response analysis showed that, in the R27 variant, TAM and OH-TAM acquired the ability to induce the M(r) 52,000 protein at concentrations compatible with their relative affinities for the estrogen receptor, while these antiestrogens were inefficient in the wild MCF7 cells. Whereas the relative increase of the M(r) 52,000 protein was similar with TAM, OH-TAM, and 17β-estradiol, the general production of M(r) 52,000 and of total labelled proteins was less with the antiestrogens than with 17β-estradiol. Moreover, OH-TAM displayed a biphasic dose-response curve with inhibitory effects at concentrations above 10 nM, suggesting an additional mechanism. Neither TAM nor OH-TAM had any antiestrogenic effect when added in the presence of 17β-estradiol. In the R27 variant, both estradiol and antiestrogens induced the progesterone receptor sites; however, the extent of the stimulation was lower with antiestrogens than with estradiol. This study shows that, in addition to the classical antiestrogen-resistant breast cancer cells, in which the estrogen receptor is absent or inactive, there is another class of antiestrogen-resistant cells in which the drug becomes a full estrogen agonist as evidenced by the induction of the M(r) 52,000 estrogen-specific protein, which is not induced in the wild-type cells.",
author = "F. Vignon and Lippman, {Marc E} and H. Nawata and D. Derocq and H. Rochefort",
year = "1984",
month = "7",
day = "5",
language = "English",
volume = "44",
pages = "2084--2088",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells

AU - Vignon, F.

AU - Lippman, Marc E

AU - Nawata, H.

AU - Derocq, D.

AU - Rochefort, H.

PY - 1984/7/5

Y1 - 1984/7/5

N2 - In an attempt to approach the mechanism by which estrogen and antiestrogen regulate the growth of estrogen receptor-positive breast cancer, we have studied the effects of the antiestrogens tamoxifen (TAM) and 4-hydroxytamoxifen (OH-TAM) on the induction of two estrogen-specific proteins in a variant of MCF7 cells termed R27, cloned for its ability to grow in the presence of TAM. We found that, in the R27 variant, antiestrogens as well as estradiol were able to increase specifically the production of a M(r) 52,000 protein which was released into the culture medium. This protein was shown to be identical to the M(r) 52,000 glycoprotein induced by estrogen and released by MCF7 cells on the basis of its specific inducibility by physiological concentrations of 17β-estradiol and of its resolution in two-dimensional gel analysis. Dose-response analysis showed that, in the R27 variant, TAM and OH-TAM acquired the ability to induce the M(r) 52,000 protein at concentrations compatible with their relative affinities for the estrogen receptor, while these antiestrogens were inefficient in the wild MCF7 cells. Whereas the relative increase of the M(r) 52,000 protein was similar with TAM, OH-TAM, and 17β-estradiol, the general production of M(r) 52,000 and of total labelled proteins was less with the antiestrogens than with 17β-estradiol. Moreover, OH-TAM displayed a biphasic dose-response curve with inhibitory effects at concentrations above 10 nM, suggesting an additional mechanism. Neither TAM nor OH-TAM had any antiestrogenic effect when added in the presence of 17β-estradiol. In the R27 variant, both estradiol and antiestrogens induced the progesterone receptor sites; however, the extent of the stimulation was lower with antiestrogens than with estradiol. This study shows that, in addition to the classical antiestrogen-resistant breast cancer cells, in which the estrogen receptor is absent or inactive, there is another class of antiestrogen-resistant cells in which the drug becomes a full estrogen agonist as evidenced by the induction of the M(r) 52,000 estrogen-specific protein, which is not induced in the wild-type cells.

AB - In an attempt to approach the mechanism by which estrogen and antiestrogen regulate the growth of estrogen receptor-positive breast cancer, we have studied the effects of the antiestrogens tamoxifen (TAM) and 4-hydroxytamoxifen (OH-TAM) on the induction of two estrogen-specific proteins in a variant of MCF7 cells termed R27, cloned for its ability to grow in the presence of TAM. We found that, in the R27 variant, antiestrogens as well as estradiol were able to increase specifically the production of a M(r) 52,000 protein which was released into the culture medium. This protein was shown to be identical to the M(r) 52,000 glycoprotein induced by estrogen and released by MCF7 cells on the basis of its specific inducibility by physiological concentrations of 17β-estradiol and of its resolution in two-dimensional gel analysis. Dose-response analysis showed that, in the R27 variant, TAM and OH-TAM acquired the ability to induce the M(r) 52,000 protein at concentrations compatible with their relative affinities for the estrogen receptor, while these antiestrogens were inefficient in the wild MCF7 cells. Whereas the relative increase of the M(r) 52,000 protein was similar with TAM, OH-TAM, and 17β-estradiol, the general production of M(r) 52,000 and of total labelled proteins was less with the antiestrogens than with 17β-estradiol. Moreover, OH-TAM displayed a biphasic dose-response curve with inhibitory effects at concentrations above 10 nM, suggesting an additional mechanism. Neither TAM nor OH-TAM had any antiestrogenic effect when added in the presence of 17β-estradiol. In the R27 variant, both estradiol and antiestrogens induced the progesterone receptor sites; however, the extent of the stimulation was lower with antiestrogens than with estradiol. This study shows that, in addition to the classical antiestrogen-resistant breast cancer cells, in which the estrogen receptor is absent or inactive, there is another class of antiestrogen-resistant cells in which the drug becomes a full estrogen agonist as evidenced by the induction of the M(r) 52,000 estrogen-specific protein, which is not induced in the wild-type cells.

UR - http://www.scopus.com/inward/record.url?scp=0021333951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021333951&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 2084

EP - 2088

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -